Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis

To study the currently available data of recurrence rates of functioning and nonfunctioning pituitary adenomas following surgical cure and to analyze associated predisposing factors, which are not well established. A systematic literature search was conducted using Medline, Embase, Web of Science and the Cochran Library for studies reporting data on recurrence of pituitary adenoma after surgery, in nonfunctioning adenoma (NF), prolactinoma (PRL) acromegaly (ACRO) and Cushing’s disease (CUSH). Of 557 initially retrieved potential relevant studies 143 were selected. Recurrence in NFA was defined as reappearance of tumor on MRI or CT. Increase of hormone levels above normal limits as set by the authors after initial remission was used to indicate recurrence in the functioning tumor types. Remission percentage was lowest in NFA compared with other tumor types (P < 0.001). Surgery-related hypopituitarism was more frequent in CUSH than in the other tumors (P < 0.001). Recurrence, expressed as percentage of the cured population or as ratio of recurrence and total patient years of follow-up was highest in PRL (P < 0.001). The remission percentage did not improve over 3 decades of publications, but there was a modest decrease in recurrence rate (P = 0.04). Recurrences peaked between 1 and 5 years after surgery. Most of the studies with a sufficient number of recurrences did not apply multivariate statistics, and mentioned at best associated factors. Age, gender, tumor size and invasion were generally unrelated to recurrence. For functioning adenomas a low postoperative hormone concentration was a prognostically favorable factor. In NFA no specific factor predicted recurrence. Recurrence rate differs between pituitary adenomas, being highest in patients with prolactinoma, with the highest incidence of recurrence between 1 and 5 years after surgery in all adenomas. Patients with NFA have a lower chance of remission than patients with functioning adenomas. The postoperative basal hormone level is the most important predictor for recurrence in functioning adenomas, while in NFA no single convincing factor could be identified.

[1]  B. Scheithauer,et al.  Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience , 2009, Clinical endocrinology.

[2]  F. Roelfsema,et al.  Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. , 2000, The Journal of clinical endocrinology and metabolism.

[3]  Surgical treatment of prolactinomas. Short- and long-term results, prognostic factors. , 1985, Hormone research.

[4]  N. Watts,et al.  Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures. , 1990, Journal of neurosurgery.

[5]  B. Ambrosi,et al.  Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly. , 1983, Journal of neurosurgery.

[6]  J. Hardy,et al.  Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. , 1983, The New England journal of medicine.

[7]  M. Hunn,et al.  Non‐functioning pituitary adenomas: indications for postoperative radiotherapy , 2000, Clinical endocrinology.

[8]  X. Bertagna,et al.  Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970-1988). , 1993, The European journal of medicine.

[9]  Shu-yuan Yang,et al.  Transsphenoidal microsurgical management of pituitary adenomas , 1994, Microsurgery.

[10]  C Hagen,et al.  Incidence and late prognosis of cushing's syndrome: a population-based study. , 2001, The Journal of clinical endocrinology and metabolism.

[11]  J. Tyrrell,et al.  Transsphenoidal microsurgical management of Cushing's disease. Report of 100 cases. , 1983, Journal of neurosurgery.

[12]  J. Hardy,et al.  Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. , 1985, The Journal of clinical endocrinology and metabolism.

[13]  D. Ross,et al.  Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. , 1988, Journal of neurosurgery.

[14]  V. Esposito,et al.  Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients , 2004, Neurological Sciences.

[15]  A. Grossman,et al.  Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure , 1996, Clinical endocrinology.

[16]  E. Laws,et al.  Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. , 2008, The Journal of clinical endocrinology and metabolism.

[17]  W. Couldwell,et al.  Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. , 2002, Journal of neurosurgery.

[18]  P. Singer,et al.  Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. , 2003, Journal of neurosurgery.

[19]  M. Losa,et al.  Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. , 2008, Journal of neurosurgery.

[20]  C. Ronchi,et al.  Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria. , 2005, The Journal of clinical endocrinology and metabolism.

[21]  A. Morabito,et al.  Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. , 2006, European journal of endocrinology.

[22]  P. Black,et al.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.

[23]  M. Esiri,et al.  TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME? , 1990, Clinical endocrinology.

[24]  M. Buchfelder,et al.  Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. , 1995, The Journal of clinical endocrinology and metabolism.

[25]  G. Tomei,et al.  Assessment of Cure and Recurrence After Pituitary Surgery for Cushing's Disease , 2001, Acta Neurochirurgica.

[26]  S. Sawano,et al.  Retrospective analysis of long‐term surgical results in acromegaly: preoperative and postoperative factors predicting outcome , 1996, Clinical endocrinology.

[27]  H. von Holst,et al.  Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases. , 2004, Journal of neurosurgery.

[28]  M. Boscaro,et al.  Risk factors and long-term outcome in pituitary-dependent Cushing's disease. , 1996, The Journal of clinical endocrinology and metabolism.

[29]  M. Czepielewski,et al.  Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[30]  C. Sweep,et al.  Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease. , 2006, European journal of endocrinology.

[31]  J. Gondim,et al.  Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center , 2009, Pituitary.

[32]  J. Wass,et al.  Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? , 1999, European journal of endocrinology.

[33]  J. Lachuer,et al.  Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. , 2010, The Journal of clinical endocrinology and metabolism.

[34]  J. Acebes,et al.  Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease , 2007, Acta Neurochirurgica.

[35]  C. Wilson,et al.  Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas. A review of 137 cases. , 1982, Journal of neurosurgery.

[36]  J. Doppman,et al.  Early repeat surgery for persistent Cushing's disease. , 1994, Journal of neurosurgery.

[37]  F. Dekker,et al.  Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. , 2004, The Journal of clinical endocrinology and metabolism.

[38]  F. Peillon,et al.  Surgical Treatment of Prolactinomas , 1985 .

[39]  W. Farrell,et al.  Molecular Pathogenesis of Pituitary Tumors , 2000, Frontiers in Neuroendocrinology.

[40]  Charles B. Wilson,et al.  Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. , 2008, Journal of neurosurgery.

[41]  R. Fahlbusch,et al.  Long-term follow-up results in hormonally active pituitary adenomas after primary successful transsphenoidal surgery. , 1991, Acta neurochirurgica. Supplementum.

[42]  S. Wardlaw,et al.  Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. , 1998, Journal of neurosurgery.

[43]  F. Esposito,et al.  Early Morning Cortisol Levels as a Predictor of Remission After Transsphenoidal Surgery for Cushing’s Disease , 2006 .

[44]  R. Fahlbusch,et al.  The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. , 2005, European journal of endocrinology.

[45]  M. Molitch,et al.  Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma. , 1984, JAMA.

[46]  J. Moossy,et al.  Factors in predicting outcome from operation in patients with prolactin-secreting pituitary adenomas. , 1983, Neurosurgery.

[47]  J. Ahlquist,et al.  A spectrum of behaviour in silent corticotroph pituitary adenomas , 2005, British journal of neurosurgery.

[48]  E. Ghigo,et al.  LONG‐TERM FOLLOW‐UP OF‘CURED’PROLACTINOMA PATIENTS AFTER SUCCESSFUL ADENOMECTOMY , 1990, Clinical endocrinology.

[49]  R. Fenstermaker,et al.  Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. , 1987, The Journal of laboratory and clinical medicine.

[50]  C. Wilson,et al.  Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up. , 1996, The Journal of clinical endocrinology and metabolism.

[51]  G. Maira,et al.  Prolactin-secreting adenomas: surgical results and long-term follow-up. , 1989, Neurosurgery.

[52]  R. Fahlbusch,et al.  Present status of neurosurgery in the treatment of prolactinomas , 2005, Neurosurgical Review.

[53]  E. Oldfield,et al.  The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. , 2011, The Journal of clinical endocrinology and metabolism.

[54]  G. Teasdale,et al.  Ten year follow up of microprolactinoma treated by transsphenoidal surgery , 1994, BMJ.

[55]  V. Esposito,et al.  Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. , 2003, Endocrine-related cancer.

[56]  A. Douglas-Jones,et al.  Low recurrence rate after partial hypophysectomyfor prolactinoma: the predictive value ofdynamic prolactin function tests , 1992, Clinical endocrinology.

[57]  B. Sherman,et al.  Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors. , 1986, The Journal of clinical endocrinology and metabolism.

[58]  J. Hardy,et al.  The clinical and endocrine outcome to trans‐sphenoidal microsurgery of nonsecreting pituitary adenomas , 1991, Cancer.

[59]  F. Roelfsema,et al.  Postoperative persistent thyrotrophin releasing hormone‐induced growth hormone release predicts recurrence in patients with acromegaly , 2002, Clinical endocrinology.

[60]  C. Invitti,et al.  Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. , 1999, The Journal of clinical endocrinology and metabolism.

[61]  O. Dekkers,et al.  Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. , 2008, The Journal of clinical endocrinology and metabolism.

[62]  Eun Jig Lee,et al.  TUMOR TISSUE IDENTIFICATION IN THE PSEUDOCAPSULE OF PITUITARY ADENOMA: SHOULD THE PSEUDOCAPSULE BE REMOVED FOR TOTAL RESECTION OF PITUITARY ADENOMA? , 2009, Neurosurgery.

[63]  Tetsuo Kato,et al.  Long term results of transsphenoidal adenomectomy in patients with Cushing's disease. , 1987, Neurosurgery.

[64]  P. Chanson,et al.  Current management practices for acromegaly: an international survey , 2011, Pituitary.

[65]  X. Bertagna,et al.  Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. , 1988, The Journal of clinical endocrinology and metabolism.

[66]  Stratton,et al.  Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience , 1999, Clinical endocrinology.

[67]  Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. , 1998, The Journal of clinical endocrinology and metabolism.

[68]  P. Derome,et al.  Treatment of Cushing’s disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up , 1996, Journal of endocrinological investigation.

[69]  A. Klibanski,et al.  Delayed remission after transsphenoidal surgery in patients with Cushing's disease. , 2010, The Journal of clinical endocrinology and metabolism.

[70]  M. Bramnert,et al.  Early postoperative basal serum GH level and the GH response to TRH in relation to the long‐term outcome of surgical treatment for acromegaly: a report on 39 patients , 1991, Journal of internal medicine.

[71]  V. Esposito,et al.  Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results. , 2007, Surgical neurology.

[72]  B. Scheithauer,et al.  Results of surgical treatment for growth hormone-secreting pituitary adenomas. , 1993, Journal of neurosurgery.

[73]  C. Burke,et al.  An audit of selected patients with non‐functioning pituitary adenoma treated by transsphenoidal surgery without irradiation , 1994, Clinical endocrinology.

[74]  Z. Ram,et al.  Transsphenoidal Surgery for Acromegaly: Endocrinological Follow-up of 98 Patients , 2001, Neurosurgery.

[75]  M. Kabil,et al.  Fully Endoscopic Endonasal vs. Transseptal Transsphenoidal Pituitary Surgery , 2005, Minimally invasive neurosurgery : MIN.

[76]  Charles B. Wilson,et al.  Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas , 2010, Pituitary.

[77]  G. Tindall,et al.  Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas. , 1982, Journal of Neurosurgery.

[78]  W. Couldwell,et al.  Assessment of long-term remission of acromegaly following surgery. , 2003, Journal of neurosurgery.

[79]  S. Lamberts,et al.  Biochemical Predictors of Outcome of Pituitary Surgery for Cushing’s Disease , 2009, Neuroendocrinology.

[80]  A. Hermus,et al.  Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease. , 1989, The Journal of clinical endocrinology and metabolism.

[81]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[82]  P. Kendall‐Taylor,et al.  Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? , 2001, Clinical endocrinology.

[83]  S. Wardlaw,et al.  Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.

[84]  C. Raftopoulos,et al.  Outcome of transsphenoidal surgery for Cushing's disease: A high remission rate in ACTH-secreting macroadenomas , 2009, Clinical Neurology and Neurosurgery.

[85]  John A. Cowan,et al.  The Role of Radiation Therapy after Surgical Resection of Nonfunctional Pituitary Macroadenomas , 2004, Neurosurgery.

[86]  J. Neal,et al.  Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. , 2003, The Journal of clinical endocrinology and metabolism.

[87]  J. Romijn,et al.  Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. , 2003, The Journal of clinical endocrinology and metabolism.

[88]  D. Rees,et al.  Long‐term follow‐up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission , 2002, Clinical endocrinology.

[89]  J. Hardy,et al.  Cushing's disease: a correlation of radiological, surgical and pathological findings with therapeutic results. , 1991, Pathology, research and practice.

[90]  D. Okonkwo,et al.  Clinical Characteristics of Silent Corticotrophic Adenomas and Creation of an Internet-accessible Database to Facilitate Their Multi-institutional Study , 2003, Neurosurgery.

[91]  A. Isidori,et al.  Androgens, cardiovascular disease and osteoporosis. , 2005, Journal of endocrinological investigation.

[92]  M. Vance,et al.  Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. , 2001, The Journal of clinical endocrinology and metabolism.

[93]  K. Lillehei,et al.  Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. , 1998, Neurosurgery.

[94]  J. Pruvo,et al.  MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas. , 2002, European journal of endocrinology.

[95]  Stratton,et al.  Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation — a follow‐up study , 1999, Clinical endocrinology.

[96]  Charles B. Wilson,et al.  Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. , 2004, The Journal of clinical endocrinology and metabolism.

[97]  T. Sano,et al.  Gene expression study of thyrotropin releasing hormone (TRH) receptor using RT-PCR: relationship to clinical and immunohistochemical phenotypes in a series of human pituitary adenomas. , 2003, Endocrine journal.

[98]  J. Brodkey,et al.  Gradual recovery of lactotroph responsiveness to dynamic stimulation following surgical removal of prolactinomas: long-term follow-up studies. , 1986, Metabolism: clinical and experimental.

[99]  T. Suda,et al.  Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery. , 2001, Endocrine journal.

[100]  Bainan Xu,et al.  A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome , 2011, Journal of Neuro-Oncology.

[101]  J. K. Henderson,et al.  A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome. , 1990, Acta Endocrinologica.

[102]  Sun Wook Cho,et al.  Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas , 2010, Clinical endocrinology.

[103]  Z. Ram,et al.  Transsphenoidal Surgery for Cushing’s Disease: Endocrinological Follow-up Monitoring of 82 Patients , 2002, Neurosurgery.

[104]  M. Losa,et al.  Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. , 1996, The Journal of clinical endocrinology and metabolism.

[105]  C. Ronchi,et al.  Adequacy of current postglucose GH nadir limit (< 1 µg/l) to define long‐lasting remission of acromegalic disease , 2007, Clinical endocrinology.

[106]  U. Knappe,et al.  The Use of Postoperative ACTH Levels as a Marker for Successful Transsphenoidal Microsurgery in Cushing’s Disease , 2003, Zentralblatt fur Neurochirurgie.

[107]  P. Kendall‐Taylor,et al.  Factors determining the long-term outcome of surgery for acromegaly. , 1994, QJM : monthly journal of the Association of Physicians.

[108]  N. Pouratian,et al.  Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. , 2008, Journal of neurosurgery.

[109]  L. Sheeler,et al.  Recurrent Cushing's disease after transsphenoidal surgery. , 1992, Archives of internal medicine.

[110]  B. Scheithauer,et al.  Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. , 1986, Journal of neurosurgery.

[111]  F. Esposito,et al.  Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. , 2006, Journal of Clinical Endocrinology and Metabolism.

[112]  Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: results and follow-up. , 1988, Acta endocrinologica.

[113]  J. Tyrrell,et al.  Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. , 1988, Annals of internal medicine.

[114]  A. Klibanski,et al.  Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease , 1999, Annals of Internal Medicine.

[115]  M. Buchfelder,et al.  Pituitary Surgery for Cushing’s Disease , 2010, Neuroendocrinology.

[116]  P. Freda,et al.  Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. , 2004, The Journal of clinical endocrinology and metabolism.

[117]  J. Hardy,et al.  Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up. , 1996, Surgical neurology.

[118]  J. Hassoun,et al.  Transsphenoidal surgery for acromegaly--long-term results in 100 patients. , 1985, Surgical neurology.

[119]  Demet Özgil.  Medical Therapy of Acromegaly , 2006 .

[120]  J. Wass,et al.  Undetectable postoperative cortisol does not always predict long‐term remission in Cushing’s disease: a single centre audit * , 2002, Clinical endocrinology.

[121]  C. Nimsky,et al.  Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. , 2008, European journal of endocrinology.

[122]  R. Magallón,et al.  Experience in management of 51 non-functioning pituitary adenomas: Indications for post-operative radiotherapy , 2005, Journal of endocrinological investigation.

[123]  L. Behan,et al.  The natural history of surgically treated but radiotherapy‐naïve nonfunctioning pituitary adenomas , 2009, Clinical endocrinology.

[124]  K. Lamborn,et al.  Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. , 1999, Neurosurgery.

[125]  C. Invitti,et al.  Diagnosis and management of Cushing's syndrome : Results of an Italian multicentre study , 1999 .

[126]  G. Teasdale,et al.  Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma. , 1985, The Quarterly journal of medicine.

[127]  A. Manni,et al.  Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. , 1980, The Journal of clinical endocrinology and metabolism.

[128]  J. Hardy,et al.  Relapse of hyperprolactinemia revisited. , 1993, The New England journal of medicine.

[129]  J. Romijn,et al.  Treatment strategies for acromegaly , 2005, Expert opinion on emerging drugs.

[130]  F. Farrokhyar,et al.  Purely endoscopic transsphenoidal surgery versus traditional microsurgery for resection of pituitary adenomas: systematic review. , 2011, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale.

[131]  R. Fahlbusch,et al.  Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. , 2008, Journal of neurosurgery.

[132]  P. Chanson,et al.  Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. , 2004, The Journal of clinical endocrinology and metabolism.

[133]  E. Laws,et al.  The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. , 2002, Journal of neurosurgery.

[134]  N. Woodhouse,et al.  Classical pituitary apoplexy presentation and a follow-up of 13 patients. , 1989, Hormone research.

[135]  J. Thomson,et al.  TRANSSPHENOIDAL MICROSURGERY FOR CUSHING'S DISEASE , 1984, Clinical endocrinology.

[136]  Y. Segev,et al.  Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth , 2003, Clinical endocrinology.

[137]  M. Hourihan,et al.  Non-Secretory Adenomas of the Pituitary Treated by Trans-Ethmoidal Sellotomy , 1991, Journal of the Royal Society of Medicine.

[138]  J. Hardy,et al.  Long‐term outcome and mortality after transsphenoidal adenomectomy for acromegaly , 2003, Clinical endocrinology.

[139]  H. Boecher-Schwarz,et al.  Treatment results of acromegaly as analyzed by different criteria , 2005, Acta Neurochirurgica.

[140]  O. Dekkers,et al.  Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. , 2010, The Journal of clinical endocrinology and metabolism.

[141]  G. Neuloh,et al.  Endocrinological Outcome Following First Time Transsphenoidal Surgery for GH-, ACTH-, and PRL-Secreting Pituitary Adenomas , 2002, Acta Neurochirurgica.

[142]  D. Lüdecke,et al.  Results of microsurgery in Cushing's disease and effect on hypertension. , 1985, Cardiology.

[143]  D. McCance,et al.  Long‐term remission rates after pituitary surgery for Cushing's disease: the need for long‐term surveillance , 2005, Clinical endocrinology.

[144]  D. Lüdecke,et al.  Transsphenoidal Microsurgery for Newly Diagnosed Acromegaly: A Personal View after More than 1,000 Operations , 2006, Neuroendocrinology.

[145]  M. Losa,et al.  Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. , 1989, Journal of neurosurgery.

[146]  Victor M Montori,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[147]  J. Gondim,et al.  Rathke's cleft cyst and partial feet adactyly: an unusual association. , 2007, Arquivos de neuro-psiquiatria.

[148]  Neil Duggal,et al.  Microscopic versus endoscopic pituitary surgery: A systematic review , 2010, The Laryngoscope.

[149]  N. Dorward.  Endocrine outcomes in Endoscopic Pituitary Surgery: A Literature Review , 2010, Acta Neurochirurgica.

[150]  D. McCance,et al.  Assessment of cure after transsphenoidal surgery for Cushing's disease , 1996, Clinical endocrinology.

[151]  C. Nordström,et al.  Early postoperative growth hormone levels: high predictive value for long‐term outcome after surgery for acromegaly , 2000, Journal of internal medicine.

[152]  F. Parl,et al.  Late recurrence of surgically removed prolactinomas , 1986, Cancer.

[153]  B. Rilliet,et al.  [Pituitary adenoma secreting prolactin. Results of their surgical treatment]. , 1996, Neuro-Chirurgie.

[154]  M. Zwahlen,et al.  Treatment outcomes and mortality of 94 patients with acromegaly , 2005, Acta Neurochirurgica.

[155]  P. Chanson,et al.  Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. , 2010, European journal of endocrinology.

[156]  B. Scheithauer,et al.  Clinically Silent Corticotroph Tumors of the Pituitary Gland , 2000, Neurosurgery.

[157]  D. Lowe,et al.  Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatment , 1993, Clinical endocrinology.

[158]  L. Auer,et al.  The first 100 transsphenoidally operated pituitary adenomas in a non-specialised centre: surgical results and tumour-recurrence. , 1985, Neurological research.

[159]  K. Lamborn,et al.  Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. , 1998, The Journal of clinical endocrinology and metabolism.

[160]  L. Talbert,et al.  Prolactin-secreting pituitary adenomas: neurosurgical management of 37 patients. , 1982, Fertility and sterility.